S&P 500   3,865.09 (-1.54%)
DOW   31,632.63 (-1.03%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   231.53 (-1.29%)
FB   257.92 (-2.42%)
GOOGL   2,038.03 (-2.20%)
AMZN   3,102.09 (-1.82%)
TSLA   701.50 (-5.46%)
NVDA   539.13 (-7.04%)
BABA   244.50 (-2.33%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.32 (-6.83%)
AMD   83.56 (-3.89%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.34 (-1.60%)
BA   221.14 (-3.58%)
NFLX   541.93 (-2.07%)
BAC   36.32 (-0.16%)
S&P 500   3,865.09 (-1.54%)
DOW   31,632.63 (-1.03%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   231.53 (-1.29%)
FB   257.92 (-2.42%)
GOOGL   2,038.03 (-2.20%)
AMZN   3,102.09 (-1.82%)
TSLA   701.50 (-5.46%)
NVDA   539.13 (-7.04%)
BABA   244.50 (-2.33%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.32 (-6.83%)
AMD   83.56 (-3.89%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.34 (-1.60%)
BA   221.14 (-3.58%)
NFLX   541.93 (-2.07%)
BAC   36.32 (-0.16%)
S&P 500   3,865.09 (-1.54%)
DOW   31,632.63 (-1.03%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   231.53 (-1.29%)
FB   257.92 (-2.42%)
GOOGL   2,038.03 (-2.20%)
AMZN   3,102.09 (-1.82%)
TSLA   701.50 (-5.46%)
NVDA   539.13 (-7.04%)
BABA   244.50 (-2.33%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.32 (-6.83%)
AMD   83.56 (-3.89%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.34 (-1.60%)
BA   221.14 (-3.58%)
NFLX   541.93 (-2.07%)
BAC   36.32 (-0.16%)
S&P 500   3,865.09 (-1.54%)
DOW   31,632.63 (-1.03%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   231.53 (-1.29%)
FB   257.92 (-2.42%)
GOOGL   2,038.03 (-2.20%)
AMZN   3,102.09 (-1.82%)
TSLA   701.50 (-5.46%)
NVDA   539.13 (-7.04%)
BABA   244.50 (-2.33%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.32 (-6.83%)
AMD   83.56 (-3.89%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.34 (-1.60%)
BA   221.14 (-3.58%)
NFLX   541.93 (-2.07%)
BAC   36.32 (-0.16%)
Log in
OTCMKTS:GRRMF

Gerresheimer Stock Forecast, Price & News

$106.90
0.00 (0.00 %)
(As of 02/24/2021 12:00 AM ET)
Add
Today's Range
$106.90
Now: $106.90
$106.90
50-Day Range
$106.90
MA: $106.90
$106.90
52-Week Range
$71.41
Now: $106.90
$119.50
Volume43 shs
Average Volume731 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and skin care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for diabetes or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:GRRMF
CUSIPN/A
CIKN/A
Phone49 211 6181 00
Employees9,890
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$106.90
0.00 (0.00 %)
(As of 02/24/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GRRMF News and Ratings via Email

Sign-up to receive the latest news and ratings for GRRMF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Gerresheimer (OTCMKTS:GRRMF) Frequently Asked Questions

Is Gerresheimer a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Gerresheimer stock.
View analyst ratings for Gerresheimer
or view top-rated stocks.

What stocks does MarketBeat like better than Gerresheimer?

Wall Street analysts have given Gerresheimer a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Gerresheimer wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Gerresheimer?

Gerresheimer saw a increase in short interest in January. As of January 29th, there was short interest totaling 64,700 shares, an increase of 33.4% from the January 14th total of 48,500 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 647.0 days.
View Gerresheimer's Short Interest
.

How has Gerresheimer's stock been impacted by COVID-19?

Gerresheimer's stock was trading at $75.3594 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GRRMF shares have increased by 41.9% and is now trading at $106.90.
View which stocks have been most impacted by COVID-19
.

Who are Gerresheimer's key executives?

Gerresheimer's management team includes the following people:
  • Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 58)
  • Dr. Bernd Metzner, CFO & Member of the Management Board (Age 51)
  • Dr. Lukas Burkhardt, Member of the Management Board (Age 42)
  • Ms. Katja Schnitzler, Group Sr. Director of EHS, CSR & OPEX and Member of Supervisory Board (Age 40)
  • Ms. Carolin Nadilo, Corp. Director of Investor Relations
  • Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media
  • Mr. Helmut Schweiger, MD & GM of Gerresheimer Horsovsky Tyn Plant

What is Gerresheimer's stock symbol?

Gerresheimer trades on the OTCMKTS under the ticker symbol "GRRMF."

How do I buy shares of Gerresheimer?

Shares of GRRMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Gerresheimer's stock price today?

One share of GRRMF stock can currently be purchased for approximately $106.90.

How many employees does Gerresheimer have?

Gerresheimer employs 9,890 workers across the globe.

What is Gerresheimer's official website?

The official website for Gerresheimer is www.gerresheimer.com.

How can I contact Gerresheimer?

The company can be reached via phone at 49 211 6181 00.


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.